Cordasco Financial Network Gt Biopharma, Inc. Transaction History

Cordasco Financial Network

  • $138 Million
  • Q2 2022
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022
BUY
$1.64 - $3.11 $0 - $0
0 New
0 $0
Q1 2022

Apr 21, 2022
BUY
$2.6 - $3.3 $0 - $0
0 New
0 $0
Q4 2021

Jan 24, 2022
BUY
$3.05 - $7.08 $0 - $0
0 New
0 $0
Q3 2021

Nov 12, 2021
BUY
$6.68 - $15.26 $0 - $0
0 New
0 $0
Q2 2021

Jul 29, 2021
BUY
$7.19 - $18.96 $0 - $0
0 New
0 $0
Q1 2021

Apr 12, 2021
BUY
$4.4 - $8.84 $0 - $0
0 New
0 $0

Others Institutions Holding GTBP

# of Institutions
4
Shares Held
564
Call Options Held
0
Put Options Held
0
View Full List

About GT Biopharma, Inc.

GTBP Quotes by TradingView
  • Ticker GTBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,557,700
  • Market Cap $98M
  • Description
  • GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...
More about GTBP
Track This Portfolio

Track Cordasco Financial Network Portfolio

Follow Cordasco Financial Network and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordasco Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on Cordasco Financial Network with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email